It is proved that 19% to 26% of DM patients will develop heart failure,[1] and 50% to 80% of DM patients will die from cardiovascular complications.[12] Current treatment measures for DC are relatively limited, and no antidiabetic drugs except sodium glucose cotransporter 2 inhibitors have obvious cardiovascular benefits. The gene discussed is SLC5A2; the disease is diabetes mellitus.